Illumina – Talk Bio

Illumina Acquires SomaLogic to Accelerate Proteomics Strategy with $350M Upfront

1 month ago talkbio0Tagged Acquisition, Biotechnology, Illumina, Proteomics, SomaLogic, Standard BioTools

Illumina; SomaLogic; Standard BioTools; proteomics; acquisition; biotechnology

Citing tariffs, Illumina slashes guidance, confirms SEC’s Grail investigation is closed

3 months ago talkbio0Tagged Acquisition (action), Divestiture, Evaluation, Grail, Illumina, SEC

Illumina, SEC, Acquisition (action), Evaluation, divestiture, Grail

Illumina and Tempus look beyond cancer in new AI-driven genomics deal

3 months ago talkbio0Tagged Artificial Intelligence, Cardiology discipline, Genetic Profile, Genomics, High-Throughput Nucleotide Sequencing, Illumina, Immunology, Malignant Neoplasms, Market, Neurology speciality, Partnership

Illumina, Genomics, Partnership, High-Throughput Nucleotide Sequencing, Malignant Neoplasms, Artificial Intelligence, Cardiology discipline, Neurology speciality, Immunology, Genetic Profile, Artificial Intelligence, Market

Illumina Reshapes Board: Former FDA Chief Takes Chair, Activist Investor Joins

4 months ago talkbio0Tagged board changes, Genomics, Illumina, Keith, Meister, Scott Gottlieb, shareholder

Illumina, Scott Gottlieb, Keith Meister, board changes, genomics, shareholder value

Illumina Announces Layoffs as Incyte Forges AI Partnership for Drug Discovery

5 months ago talkbio0Tagged Aortic Valve Insufficiency, Drug Discovery, FOXD3 gene, Gemini of Coiled Bodies, Illumina, Incyte, Partnership

Illumina, layoffs, Incyte, Genesis Therapeutics, AI partnership, drug discovery, GEMS platform, small molecule therapeutics

Illumina’s Double-Edged Sword: Navigating US-China Trade Tensions

6 months ago talkbio0Tagged BIOSECURE, China, DNA Sequence, Entity, Illumina, Industry, Tension, TNFRSF19 gene, unreliable

Illumina, China, tariffs, trade tensions, DNA sequencing, unreliable entity list, biotech industry, BIOSECURE Act

Truveta Genome Project: A Historic 10M Genome Sequencing Initiative Backed by Regeneron, Illumina, and Leading Health Systems

6 months ago talkbio0Tagged Drug Discovery, genetic sequencing, genome sequencing, Genotype, healthcare analytics, Illumina, phenotypic, Precision Medicine, Regeneron, Truveta

Truveta Genome Project, 10M genome sequencing, Regeneron, Illumina, genetic sequencing, genotypic and phenotypic data, healthcare analytics, drug discovery, personalized medicine.